Literature DB >> 25876452

Growth hormone replacement therapy and fracture risk.

Andrea Giustina1, Gherardo Mazziotti2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25876452     DOI： 10.1016/S2213-8587(15)00036-4

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  4 in total

1.  Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency.

Authors:  Gherardo Mazziotti; Mauro Doga; Stefano Frara; Filippo Maffezzoni; Teresa Porcelli; Luigi Cerri; Roberto Maroldi; Andrea Giustina
Journal:  Endocrine       Date:  2015-10-03       Impact factor: 3.633

2.  Bone safety of dual-release hydrocortisone in patients with hypopituitarism.

Authors:  Stefano Frara; Sabrina Chiloiro; Teresa Porcelli; Antonella Giampietro; Gherardo Mazziotti; Laura De Marinis; Andrea Giustina
Journal:  Endocrine       Date:  2018-01-08       Impact factor: 3.633

Review 3.  Acromegalic osteopathy.

Authors:  G Mazziotti; F Maffezzoni; S Frara; A Giustina
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

4.  Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.

Authors:  N C van Varsseveld; C C van Bunderen; A A M Franken; H P F Koppeschaar; A J van der Lely; M L Drent
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.